November 25, 2024 - 22:01

IceCure Medical Ltd. has announced that its next-generation multiprobe cryoablation technology has received a Notice of Allowance from Japan's Patent Office. This significant development marks a key milestone for the company's innovative approach to minimally invasive medical procedures.
The multiprobe cryoablation technology is designed to enhance the effectiveness and efficiency of cryoablation treatments, which are used to destroy abnormal tissues through extreme cold. This advancement is expected to provide physicians with improved tools for treating various medical conditions, potentially leading to better patient outcomes.
The approval from Japan's Patent Office underscores the technological advancements that IceCure is bringing to the field of cryoablation, positioning the company for growth in the competitive medical technology market.
January 28, 2026 - 23:46
ICE’s surveillance technology goes beyond facial recognitionFederal immigration authorities in Minnesota are operating a sophisticated and wide-ranging surveillance network that extends far beyond simple facial recognition, according to recent findings. The...
January 28, 2026 - 01:37
Students hack their way into the future of brain-computer interfacesThe future of brain-computer interfaces (BCIs) is being shaped by the next generation of innovators today. At a recent intensive hackathon, university students moved beyond theory to work directly...
January 27, 2026 - 03:01
New U.S. defense strategy ‘barely mentions technology’The Pentagon quietly released its annual National Defense Strategy (NDS) late Friday, a move that has sparked immediate analysis and concern. The unclassified, 34-page document was published online...
January 26, 2026 - 18:47
Tandem Technology to Raise $100 Million for Prescription AutomationAiming to revolutionize a critical yet often cumbersome part of healthcare, HealthTech startup Tandem Technology is embarking on a significant capital raise. The company is seeking to secure...